Cargando…
The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis
Research from over the past 20 years has implicated dipeptidyl peptidase (DPP) IV and its family members in many processes and different pathologies of the immune system. Most research has been focused on either DPPIV or just a few of its family members. It is, however, essential to consider the ent...
Autores principales: | Waumans, Yannick, Baerts, Lesley, Kehoe, Kaat, Lambeir, Anne-Marie, De Meester, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528296/ https://www.ncbi.nlm.nih.gov/pubmed/26300881 http://dx.doi.org/10.3389/fimmu.2015.00387 |
Ejemplares similares
-
Methotrexate and Cyclosporine Treatments Modify the Activities of Dipeptidyl Peptidase IV and Prolyl Oligopeptidase in Murine Macrophages
por: Olivo, R. A., et al.
Publicado: (2008) -
Prolyl carboxypeptidase activity in the circulation and its correlation with body weight and adipose tissue in lean and obese subjects
por: Kehoe, Kaat, et al.
Publicado: (2018) -
The role of prolyl oligopeptidase, understanding the puzzle
por: García-Horsman, J. Arturo
Publicado: (2020) -
Prolyl Carboxypeptidase Mediates the C-Terminal Cleavage of (Pyr)-Apelin-13 in Human Umbilical Vein and Aortic Endothelial Cells
por: De Hert, Emilie, et al.
Publicado: (2021) -
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
por: Tenorio-Laranga, Jofre, et al.
Publicado: (2010)